Before a drug manufacturer can permanently add warnings to a drug label, the Food and Drug Administration (“FDA”) must approve the addition. In Re Fosamax Alendronate Sodium Prods. Liab. Litig.. There are two different ways to implement this change....
Pliva, Inc. v. Mensing (09-993); Actavis Elizabeth, LLC v. Mensing (09-1039); Actavis, Inc. v. Demahy (09-1501) (consolidated)
(LIIBULLETIN preview (pre-2014))
Oral argument: Mar. 30, 2011
Appealed from: United States Court of Appeals for the Eighth Circuit (Nov. 27, 2009); United States Court of Appeals for the Fifth Circuit (Jan. 8, 2010)DRUGS, FAILURE-TO-WARN,...